Alkylating agent related to busulfan, q.v. Prepn and antitumor activity of the hydrochloride: M. M. El-Merzabani, Y. Sakurai, Gann 56, 589 (1965), C.A. 64, 8793b (1965); Y. Sakurai, JP 67 26616 (1967), C.A. 69, 51596f (1968). Prepn of the tosylate: M. Nakanishi et al., DE 2059377 (1971 to Yoshitomi), C.A. 75, 63127r (1972). Absorption, distribution, excretion, metabolism: Y. Kato et al., Yakugaku Zasshi 94, 1107 (1974), C.A. 82, 38441a (1975). Pharmacology: N. Brock, J. Kuhlmann, Arzneim.-Forsch. 24, 1139 (1974); H. Imamura et al., Oyo Yakuri 9, 861 (1975), C.A. 84, 12492j (1976). Antitumor effect: T. Okumoto et al., Chem. Pharm. Bull. 25, 3003 (1977); T. Iwaguchi, H. Kitagawa, Gann 69, 123 (1968), C.A. 89, 157282 (1978). Clinical study: S. J. Altman et al., Cancer 35, 1145 (1975). Toxicity study: N. Rakieten et al., U.S. NTIS Report PB-196468 (1970) 17 pp, C.A. 75, 47359n (1971). Mutagenicity study: W. F. Benedict et al., Cancer Res. 37, 2209 (1977).
Antineoplastic.
Antineoplastic; Alkylating Agents; Alkyl Sulfonates